24 nov 2015 | Updated 17 feb 2025
-
We propose using rapamycin-related mTOR inhibitors as a potential therapeutic approach for X-linked adrenoleukodystrophy (X-ALD), which is a neurometabolic disease characterized the loss of...
13 nov 2015 | Updated 17 feb 2025
-
This technology is protected by Spanish patent (P201301191). Also, a PCT application has been filed for international extension (PCT/ES2014/070921). Víctor Manuel Pérez Lozano SGITT-OTRI...
05 oct 2016 | Updated 17 feb 2025
-
On December 22, 2015, the Universitat Politècnica de València requested patent protection at the Spanish Patent and Trademark Office, with the reference P201531877. Contacto técnico Narcís Cardona...
05 oct 2016 | Updated 17 feb 2025
-
Protected by patent in Spain. Miguel Hernández University of Elche owns 57.14 % of patent rights. The remaining 42.86 % is held by the University of Burgos Mariano Almela Alarcón M.almela@umh.es...